MediFind found 7 doctor with experience in Anti-NMDA Receptor Encephalitis near Yokohama, 14. Of these, 6 are Experienced and 1 are Distinguished.
Kazutoshi Nishiyama practices in Kanagawa, Japan. Nishiyama is rated as a Distinguished expert by MediFind in the treatment of Anti-NMDA Receptor Encephalitis. Their top areas of expertise are Anti-NMDA Receptor Encephalitis, Encephalitis, Status Epilepticus, Seizures, and Thymectomy.
Tsuyoshi Ota practices in Hongo, Japan. Mr. Ota is rated as an Experienced expert by MediFind in the treatment of Anti-NMDA Receptor Encephalitis. His top areas of expertise are Uterine Fibroids, Ectopic Pregnancy, Ovarian Cancer, and Anti-NMDA Receptor Encephalitis.
Kokoro Ozaki practices in Hongo, Japan. Ms. Ozaki is rated as an Experienced expert by MediFind in the treatment of Anti-NMDA Receptor Encephalitis. Her top areas of expertise are Spinocerebellar Ataxia Type 31, Spinocerebellar Ataxia, Cerebelloolivary Atrophy, Spinocerebellar Ataxia Type 4, and Thymectomy.
Hiroki Shirai practices in Kanagawa, Japan. Mr. Shirai is rated as an Experienced expert by MediFind in the treatment of Anti-NMDA Receptor Encephalitis. His top area of expertise is Anti-NMDA Receptor Encephalitis.
Tsugio Akutsu practices in Kanagawa, Japan. Mr. Akutsu is rated as an Experienced expert by MediFind in the treatment of Anti-NMDA Receptor Encephalitis. His top areas of expertise are MELAS Syndrome, Status Epilepticus, Encephalitis, and Myasthenia Gravis.
Eiji Isozaki practices in Fuchu, Japan. Mr. Isozaki is rated as an Experienced expert by MediFind in the treatment of Anti-NMDA Receptor Encephalitis. His top areas of expertise are Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Supranuclear Ophthalmoplegia, and Brown Syndrome.
Hirofumi Kashii practices in Fuchu, Japan. Kashii is rated as an Experienced expert by MediFind in the treatment of Anti-NMDA Receptor Encephalitis. Their top areas of expertise are Myoclonic Epilepsy, West Syndrome, Cockayne Syndrome Type 1, and Tuberous Sclerosis.
Last Updated: 01/09/2026